{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:43:22Z","timestamp":1789469002374,"version":"build-2803163510"},"reference-count":50,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Epilepsy continues to be a significant global health problem and the search\nfor new drugs for its treatment remains an urgent task. 5-HT2 and GABAA-receptors are among\npromising biotargets for the search for new anticonvulsants.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>New potential 5-HT2 and GABAA ligands in the series of substituted cinnamoyl derivatives\nof 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1-(2H)-one oxime were designed using pharmacophore\nmodel and molecular docking analysis. The synthesis of new compounds was carried out from\n3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1(2H)-one oxime and substituted cinnamoyl chlorides. The\nanticonvulsant activity of new substances has been established using the maximal electroshock seizure\ntest.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Several synthesized substituted cinnamoyl derivatives of 3,4,6,7,8,9-hexahydrodibenzo\n[b,d]furan-1-(2H)-one oxime significantly reduced the severity of convulsive manifestations and\ncompletely prevented the death of animals after MES. The structure-activity relationship was investigated.\nThe most effective compound was found to be GIZH-348 (1g) (3,4,6,7,8,9-hexahydrodibenzo[\nb,d]furan-1(2\u041d)-one \u041e-(4-chlorophenyl)acryloyl)oxime) at the doses of 10-20 mg\/kg.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Molecular and pharmacophore modelling methods allowed us to create a new group of\nsubstituted cinnamoyl derivatives of 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1-(2H)-one oxime with\nanticonvulsant activity.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406419666230908121759","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T10:52:26Z","timestamp":1694429546000},"page":"92-107","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Design, Synthesis and Anticonvulsant Activity of Cinnamoyl Derivatives of 3,4,6,7,8,9-hexahydrodibenzo[b,d]furan-1-(2H)-one Oxime"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2617-0334","authenticated-orcid":true,"given":"Grigory V.","family":"Mokrov","sequence":"first","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina E.","family":"Biryukova","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana Y.","family":"Vorobieva","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andry S.","family":"Pantileev","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana S.","family":"Grigorkevich","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila A.","family":"Zhmurenko","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey G.","family":"Rebeko","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix S.","family":"Bayburtskiy","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana A.","family":"Litvinova","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Voronina","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana A.","family":"Gudasheva","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei B.","family":"Seredenin","sequence":"additional","affiliation":[{"name":"Department of Medicinal Chemistry, FSBI Zakusov Research Institute of Pharmacology, Baltiyskaya 8, Moscow,\n125315 Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","unstructured":"WHO. Epilepsy. Available from:"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1111\/epi.13084","volume":"56","author":"Begley C.E.","year":"2015","unstructured":"Begley C.E.; Durgin T.L.; The direct cost of epilepsy in the United States: A systematic review of estimates. Epilepsia 2015,56(9),1376-1387","journal-title":"Epilepsia"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1111\/epi.17165","volume":"63","author":"Begley C.","year":"2022","unstructured":"Begley C.; Wagner R.G.; Abraham A.; Beghi E.; Newton C.; Kwon C.S.; Labiner D.; Winkler A.S.; The global cost of epilepsy: A systematic review and extrapolation. Epilepsia 2022,63(4),892-903","journal-title":"Epilepsia"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.yebeh.2014.12.043","volume":"45","author":"Brandt C.","year":"2015","unstructured":"Brandt C.; Lahr D.; May T.W.; Cognitive adverse events of topiramate in patients with epilepsy and intellectual disability. Epilepsy Behav 2015,45,261-264","journal-title":"Epilepsy Behav"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.yebeh.2005.01.002","volume":"6","author":"Fritz N.","year":"2005","unstructured":"Fritz N.; Glogau S.; Hoffmann J.; Rademacher M.; Elger C.E.; Helmstaedter C.; Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005,6(3),373-381","journal-title":"Epilepsy Behav"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1212\/WNL.0b013e3181eccfb5","volume":"75","author":"White J.R.","year":"2010","unstructured":"White J.R.; Walczak T.S.; Marino S.E.; Beniak T.E.; Leppik I.E.; Birnbaum A.K.; Zonisamide discontinuation due to psychiatric and cognitive adverse events: A case-control study. Neurology 2010,75(6),513-518","journal-title":"Neurology"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.4102\/phcfm.v12i1.2162","volume":"12","author":"Mutanana N.","year":"2020","unstructured":"Mutanana N.; Tsvere M.; Chiweshe M.K.; General side effects and challenges associated with anti-epilepsy medication: A review of related literature. Afr J Prim Health Care Fam Med 2020,12(1),e1-e5","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11094-018-1763-z","volume":"52","author":"Zhmurenko L.A.","year":"2018","unstructured":"Zhmurenko L.A.; Voronina T.A.; Litvinova S.A.; Nerobkova L.N.; Gaidukov I.O.; Mokrov G.V.; Gudasheva T.A.; Synthesis and anticonvulsive activity of 3- and 4-benzoylpyridine oxime derivatives. Pharm Chem J 2018,52(1),42-51","journal-title":"Pharm Chem J"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s11094-019-01964-7","volume":"53","author":"Mokrov G.V.","year":"2019","unstructured":"Mokrov G.V.; Savel\u2019ev V.L.; Voronina T.A.; Litvinova S.A.; Kovalev I.G.; Nerobkova L.N.; Dmitrienko A.O.; Gudasheva T.A.; Seredenin S.B.; Synthesis and anticonvulsant activity of n-substituted 4-amino-3-nitrocoumarins. Pharm Chem J 2019,53(2),118-124","journal-title":"Pharm Chem J"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1007\/s00044-019-02422-5","volume":"28","author":"Mokrov G.V.","year":"2019","unstructured":"Mokrov G.V.; Litvinova S.A.; Voronina T.A.; Nerobkova L.N.; Kutepova I.S.; Kovalev I.G.; Gudasheva T.A.; Durnev A.D.; Design, synthesis, and anticonvulsant evaluation of 4-GABA-3-nitrocoumarines, 1-thiocoumarines, quinolone-2-ones, and their derivatives. Med Chem Res 2019,28(11),1901-1911","journal-title":"Med Chem Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s11094-019-01978-1","volume":"53","author":"Mokrov G.V.","year":"2019","unstructured":"Mokrov G.V.; Voronina T.A.; Litvinova S.A.; Kovalev I.G.; Nerobkova L.N.; Durnev A.D.; Gudasheva T.A.; Seredenin S.B.; Synthesis and anticonvulsant activity of 4-amino-3-nitro-1-thiocoumarins and 4-amino-3-nitroquinolin-2-ones. Pharm Chem J 2019,53(3),194-200","journal-title":"Pharm Chem J"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11094-019-02015-x","volume":"53","author":"Zhmurenko L.A.","year":"2019","unstructured":"Zhmurenko L.A.; Litvinova S.A.; Mokrov G.V.; Kovalev I.G.; Voronina T.A.; Nerobkova L.N.; Gudasheva T.A.; Synthesis of 4-phenylpyrrolidone derivatives with anticonvulsant and nootropic activity. Pharm Chem J 2019,53(5),429-435","journal-title":"Pharm Chem J"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s11094-020-02112-2","volume":"53","author":"Zhmurenko L.A.","year":"2020","unstructured":"Zhmurenko L.A.; Litvinova S.A.; Kutepova I.S.; Nerobkova L.N.; Mokrov G.V.; Rebeko A.G.; Voronina T.A.; Gudasheva T.A.; Synthesis of dibenzofuranone-oxime derivatives with anticonvulsant, antihypoxic, and anti-ischemic activity. Pharm Chem J 2020,53(11),997-1004","journal-title":"Pharm Chem J"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s11094-021-02309-z","volume":"54","author":"Zhmurenko L.A.","year":"2021","unstructured":"Zhmurenko L.A.; Litvinova S.A.; Mokrov G.V.; Ivasheva D.M.; Rebeko A.G.; Voronina T.A.; Gudasheva T.A.; Synthesis of aminoalkyl dibenzofuranone oxime derivatives possessing anticonvulsant activity. Pharm Chem J 2021,54(10),997-1002","journal-title":"Pharm Chem J"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/j.1471-4159.2006.04277.x","volume":"100","author":"Bagdy G.","year":"2007","unstructured":"Bagdy G.; Kecskemeti V.; Riba P.; Jakus R.; Serotonin and epilepsy. J Neurochem 2007,100(4),857-873","journal-title":"J Neurochem"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.neuropharm.2016.04.016","volume":"108","author":"Venzi M.","year":"2016","unstructured":"Venzi M.; David F.; Bellet J.; Cavaccini A.; Bombardi C.; Crunelli V.; Di Giovanni G.; Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures. Neuropharmacology 2016,108,292-304","journal-title":"Neuropharmacology"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1111\/jnc.15769","volume":"165","author":"Bryson A.","year":"2023","unstructured":"Bryson A.; Reid C.; Petrou S.; Fundamental neurochemistry review: GABA A receptor neurotransmission and epilepsy: Principles, disease mechanisms and pharmacotherapy. J Neurochem 2023,165(1),6-28","journal-title":"J Neurochem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.2174\/1381612823666170809100230","volume":"23","author":"Palma E.","year":"2018","unstructured":"Palma E.; Ruffolo G.; Cifelli P.; Roseti C.; Vliet E.A.; Aronica E.; Modulation of GABAA Receptors in the treatment of epilepsy. Curr Pharm Des 2018,23(37),5563-5568","journal-title":"Curr Pharm Des"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ejmech.2012.08.037","volume":"57","author":"Karakurt A.","year":"2012","unstructured":"Karakurt A.; Alag\u00f6z M.A.; Sayo\u011flu B.; \u00c7al\u0131\u015f \u00dc.; Dalkara S.; Synthesis of some novel 1-(2-naphthyl)-2-(imidazol-1-yl)ethanone oxime ester derivatives and evaluation of their anticonvulsant activity. Eur J Med Chem 2012,57,275-282","journal-title":"Eur J Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.pharep.2018.06.007","volume":"70","author":"Sari S.","year":"2018","unstructured":"Sari S.; Kaynak F.B.; Dalkara S.; Synthesis and anticonvulsant screening of 1,2,4-triazole derivatives. Pharmacol Rep 2018,70(6),1116-1123","journal-title":"Pharmacol Rep"},{"key":"ref=21","author":"Yacovan A.","year":"2006","unstructured":"Yacovan A.; Grynszpan F.; Aizikovich A.; Brody M. S.; Bar-Joseph A.; Meilin S.; Benzofuran derivatives with therapeutic activities. 2006"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1080\/10286020.2012.724400","volume":"14","author":"Hu X.","year":"2012","unstructured":"Hu X.; Wang M.; Yan G.R.; Yu M.H.; Wang H.Y.; Hou A.J.; 2-Arylbenzofuran and tyrosinase inhibitory constituents of Morus notabilis. J Asian Nat Prod Res 2012,14(12),1103-1108","journal-title":"J Asian Nat Prod Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jphs.2015.07.021","volume":"131","author":"Chen C.Y.","year":"2016","unstructured":"Chen C.Y.; Wei X.D.; Chen C.R.; 3,4,5-Trimethoxycinnamic acid, one of the constituents of Polygalae Radix exerts anti-seizure effects by modulating GABAAergic systems in mice. J Pharmacol Sci 2016,131(1),1-5","journal-title":"J Pharmacol Sci"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/molecules23010076","volume":"23","author":"Cuan Y.","year":"2017","unstructured":"Cuan Y.; He X.; Zhao Y.; Yang J.; Bai Y.; Sun Y.; Zhang Q.; Zhao Z.; Wei X.; Zheng X.; Anticonvulsant activity of halogen-substituted cinnamic acid derivatives and their effects on glycosylation of PTZ-induced chronic epilepsy in mice. Molecules 2017,23(1),76","journal-title":"Molecules"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/cmdc.201500153","volume":"10","author":"Gunia-Krzy\u017cak A.","year":"2015","unstructured":"Gunia-Krzy\u017cak A.; Pa\u0144czyk K.; Waszkielewicz A.M.; Marona H.; Cinnamamide derivatives for central and peripheral nervous system disorders: A review of structure-activity relationships. ChemMedChem 2015,10(8),1302-1325","journal-title":"ChemMedChem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1474-4422(07)70215-6","volume":"6","author":"Perucca E.","year":"2007","unstructured":"Perucca E.; French J.; Bialer M.; Development of new antiepileptic drugs: Challenges, incentives, and recent advances. Lancet Neurol 2007,6(9),793-804","journal-title":"Lancet Neurol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"ddr.21538","DOI":"10.1002\/ddr.21538","volume":"80","author":"Acar M.F.","year":"2019","unstructured":"Acar M.F.; Sari S.; Dalkara S.; Synthesis, in vivo anticonvulsant testing, and molecular modeling studies of new nafimidone derivatives. Drug Dev Res 2019,80(5),ddr.21538","journal-title":"Drug Dev Res"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fphar.2015.00046","volume":"6","author":"Guiard B.P.","year":"2015","unstructured":"Guiard B.P.; Giovanni G.D.; Central serotonin-2A (5-HT2A) receptor dysfunction in depression and epilepsy: The missing link? Front Pharmacol 2015,6,46","journal-title":"Front Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1002\/epi4.12580","volume":"7","author":"Sourbron J.","year":"2022","unstructured":"Sourbron J.; Lagae L.; Serotonin receptors in epilepsy: Novel treatment targets? Epilepsia Open 2022,7(2),231-246","journal-title":"Epilepsia Open"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.neuron.2015.03.042","volume":"86","author":"Braat S.","year":"2015","unstructured":"Braat S.; Kooy R.F.; The GABAA receptor as a therapeutic target for neurodevelopmental disorders. Neuron 2015,86(5),1119-1130","journal-title":"Neuron"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"5169","DOI":"10.1002\/ejoc.201600975","volume":"2016","author":"Peng Y.","year":"2016","unstructured":"Peng Y.; Luo J.; Feng Q.; Tang Q.; Understanding the scope of feist-b\u00e9nary furan synthesis: Chemoselectivity and diastereoselectivity of the reaction between \u03b1-halo ketones and \u03b2-dicarbonyl compounds. Eur J Org Chem 2016,2016(30),5169-5179","journal-title":"Eur J Org Chem"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"A304","DOI":"10.1021\/ed067pA304","volume":"67","author":"Kolb K.E.","year":"1990","unstructured":"Kolb K.E.; Field K.W.; Schatz P.F.; A one-step synthesis of cinnamic acids using malonic acid: The verley-doebner modification of the knoevenagel condensation. J Chem Educ 1990,67(12),A304","journal-title":"J Chem Educ"},{"key":"ref=33","first-page":"235","author":"Voronina T.A.","year":"2012","unstructured":"Voronina T.A.; Nerobkova L.N.;  In: Methodical instructions for the study of anticonvulsant activity of pharmacological substances A guide to preclinical drug research Metodicheskie ukazaniya po izucheniyu protivosudorozhnoi aktivnosti farmakologicheskikh veshchestv 2012,235-250","journal-title":"In: Methodical instructions for the study of anticonvulsant activity of pharmacological substances A guide to preclinical drug research Metodicheskie ukazaniya po izucheniyu protivosudorozhnoi aktivnosti farmakologicheskikh veshchestv"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.tetasy.2016.07.003","volume":"27","author":"Leitis Z.","year":"2016","unstructured":"Leitis Z.; L\u016bsis V.; Conjugate addition of aryl nucleophiles to \u03b1,\u03b2-unsaturated cinnamic acid derivatives containing evans type chiral auxiliaries. Tetrahedron Asymmetry 2016,27(17-18),843-851","journal-title":"Tetrahedron Asymmetry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1002\/jhet.4455","volume":"59","author":"Chen Y.","year":"2022","unstructured":"Chen Y.; Luo X.; Wang Y.; Xing Z.; Chen J.; Design and synthesis novel amide derivatives containing an 1,3,4\u2010oxadiazole moiety as potential antibacterial agents. J Heterocycl Chem 2022,59(7),1160-1168","journal-title":"J Heterocycl Chem"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ejmech.2013.04.068","volume":"65","author":"Raffa D.","year":"2013","unstructured":"Raffa D.; Maggio B.; Raimondi M.V.; Cusimano M.G.; Amico G.; Carollo A.; Conaldi P.G.; Bai R.; Hamel E.; Daidone G.; 2-Cinnamamido, 2-(3-phenylpropiolamido), and 2-(3-phenyl propanamido)benzamides: Synthesis, antiproliferative activity, and mechanism of action. Eur J Med Chem 2013,65,427-435","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"9295","DOI":"10.1021\/ma034793w","volume":"36","author":"Mikroyannidis J.A.","year":"2003","unstructured":"Mikroyannidis J.A.; Spiliopoulos I.K.; Kasimis T.S.; Kulkarni A.P.; Jenekhe S.A.; Synthesis, photophysics, and electroluminescence of conjugated poly(p -phenylenevinylene) derivatives with 1,3,4-oxadiazoles in the backbone. Macromolecules 2003,36(25),9295-9302","journal-title":"Macromolecules"},{"key":"ref=38","first-page":"109","volume":"39","author":"Nov\u00e1cek L.","year":"1990","unstructured":"Nov\u00e1cek L.; Nov\u00e1kov\u00e1 O.; Pol\u00e1sek L.; Dan\u0115k J.; Preparation of derivatives of 3-(3,4-dimethoxyphenyl)propanic acid and a study of its biological activity. Cesk Farm 1990,39(3),109-112","journal-title":"Cesk Farm"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1039\/P29950002257","author":"Kim T.H.","year":"1995","unstructured":"Kim T.H.; Huh C.; Lee B.S.; Lee I.; Nucleophilic substitution reactions of cinnamoyl chlorides with anilines in acetonitrile and acetonitrile\u2013methanol mixtures. J Chem Soc, Perkin Trans 2 1995(12),2257-2261","journal-title":"J Chem Soc, Perkin Trans 2"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1021\/jo00378a012","volume":"52","author":"Norman M.H.","year":"1987","unstructured":"Norman M.H.; Heathcock C.H.; Novel transformations leading to 3-benzylindolizidin-2-ones. J Org Chem 1987,52(2),226-235","journal-title":"J Org Chem"},{"key":"ref=41","author":"Nardi A.","unstructured":"Nardi A.; Grunnet M.; Demnitz J.; Jensen T.D.; Christophersen P.; Jones D.S.; Nielsen E.O.; Str\u00f8b\u00e6k D.; Madsen L.S.; Novel cinnamic amide derivatives useful as ion channel modulators."},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/BF00824304","volume":"126","author":"Gakhar H.K.","year":"1995","unstructured":"Gakhar H.K.; Kaur R.; Gupta S.B.; [1,3]Dioxolo[5,6][1] benzothieno[2,3-c]-quinolin-6(5H)-ones. Monatsh Chem 1995,126(11),1253-1256","journal-title":"Monatsh Chem"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/bscb.19660750703","volume":"75","author":"Rasschaert A.","year":"1966","unstructured":"Rasschaert A.; Janssens W.; Slootmaekers P.J.; A re-examination of the selectivity in the Friedel-crafts chalcone synthesis. Bull Soc Chim Belg 1966,75,449-455","journal-title":"Bull Soc Chim Belg"},{"key":"ref=44","first-page":"409","volume":"49","author":"Robinson E.R.T.","year":"2017","unstructured":"Robinson E.R.T.; Frost A.B.; El\u00edas-Rodr\u00edguez P.; Smith A.D.; Enantioselective isothiourea-catalysed michael\u2013michael\u2013lactonisation cascade reaction for the synthesis of \u03b4-lactones and 1,2,3,4-substituted cyclopentanes. Synthesis 2017,49,409-423","journal-title":"Synthesis"},{"key":"ref=45","first-page":"612","volume":"84","author":"Sharma M.L.","year":"2007","unstructured":"Sharma M.L.; Kaur S.; Synthesis of quaternary salts of ammonia from cinnamic acids and their plant growth retardant activity. J Indian Chem Soc 2007,84,612-614","journal-title":"J Indian Chem Soc"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1021\/jm0499615","volume":"47","author":"Wu Z.","year":"2004","unstructured":"Wu Z.; Minhas G.S.; Wen D.; Jiang H.; Chen K.; Zimniak P.; Zheng J.; Design, synthesis, and structure-activity relationships of haloenol lactones: Site-directed and isozyme-selective glutathione S-transferase inhibitors. J Med Chem 2004,47(12),3282-3294","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1055\/s-1978-24686","volume":"1978","author":"Coutrot P.","year":"1978","unstructured":"Coutrot P.; Snoussi M.; Savignac P.; An improvement in the wittig-horner synthesis of 2-alkenoic acids. Synthesis 1978,1978(2),133-134","journal-title":"Synthesis"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1016\/j.tet.2005.04.001","volume":"61","author":"Jim\u00e9nez V.","year":"2005","unstructured":"Jim\u00e9nez V.; Alderete J.B.; The role of charge transfer interactions in the inclusion complexation of anionic guests with \u03b1-cyclodextrin. Tetrahedron 2005,61(23),5449-5456","journal-title":"Tetrahedron"},{"key":"ref=49","first-page":"366","author":"Zhang Y.M.","year":"1981","unstructured":"Zhang Y.M.; Zhou Z.M.; Jiang F.; Synthesis of new phenols 1. derivatives of 8 hydroxy indolizine. J Chem Res Synopses 1981,366-367","journal-title":"J Chem Res Synopses"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1021\/ol800829q","volume":"10","author":"Takaya J.","year":"2008","unstructured":"Takaya J.; Tadami S.; Ukai K.; Iwasawa N.; Copper(I)-catalyzed carboxylation of aryl- and alkenylboronic esters. Org Lett 2008,10(13),2697-2700","journal-title":"Org Lett"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406419666230908121759","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/220833\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1573406419666230908121759","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T11:36:28Z","timestamp":1706182588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/220833\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406419666230908121759","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-03-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-14","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}